Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy

समान संसाधन

• Biomarkers of Treatment Toxicity in Combined-Modality Cancer Therapies with Radiation and Systemic Drugs: Study Design, Multiplex Methods, Molecular Networks
  द्वारा: Ree, Anne Hansen, और अन्य
  प्रकाशित: (2014)
• Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
  द्वारा: Kalanxhi, Erta, और अन्य
  प्रकाशित: (2017)
• Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
  द्वारा: Kalanxhi, Erta, और अन्य
  प्रकाशित: (2016)
• Tumor Phosphatidylinositol-3-Kinase Signaling and Development of Metastatic Disease in Locally Advanced Rectal Cancer
  द्वारा: Ree, Anne Hansen, और अन्य
  प्रकाशित: (2012)
• Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
  द्वारा: Meltzer, Sebastian, और अन्य
  प्रकाशित: (2016)